These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 1621078)

  • 1. [Somatostatin analog (octreotide) in clinical use: current and potential indications].
    Meier R; Dierdorf R; Gyr K
    Schweiz Med Wochenschr; 1992 Jun; 122(25):957-68. PubMed ID: 1621078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Future medical prospects for Sandostatin.
    Harris AG
    Z Gastroenterol; 1990 Sep; 28 Suppl 2():55-60. PubMed ID: 1980778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Somatostatin and its analogs in the treatment of gastrointestinal and liver diseases].
    Feu F; Bosch J
    Gastroenterol Hepatol; 1996 Feb; 19(2):68-77. PubMed ID: 8616683
    [No Abstract]   [Full Text] [Related]  

  • 4. Emerging indications for octreotide therapy, Part 1.
    Mosdell KW; Visconti JA
    Am J Hosp Pharm; 1994 May; 51(9):1184-92. PubMed ID: 8042637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of somatostatin analogue for intestinal and pancreatic fistulas].
    Paran H; Neufeld D; Epstein T; Bendahan J; Freund U
    Harefuah; 1991 Feb; 120(4):185-6. PubMed ID: 2066018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Theoretical and physiopharmacological bases of the somatostatin treatment in digestive diseases].
    Consolo F; Pustorino S
    Minerva Chir; 1992 Apr; 47(8):723-9. PubMed ID: 1351277
    [No Abstract]   [Full Text] [Related]  

  • 7. Octreotide, a new somatostatin analogue.
    Katz MD; Erstad BL
    Clin Pharm; 1989 Apr; 8(4):255-73. PubMed ID: 2653711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of gastrointestinal neuroendocrine tumors with the somatostatin analog octreotide (Sandostatin)].
    Stöckmann F; Creutzfeldt W
    Z Gastroenterol; 1988 Oct; 26(10):665-75. PubMed ID: 2849248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential indications for octreotide in gastroenterology: summary of workshop.
    Burroughs AK; Malagelada R
    Digestion; 1993; 54 Suppl 1():59-67. PubMed ID: 8359570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NIH conference. Somatostatin and somatostatin analogue (SMS 201-995) in treatment of hormone-secreting tumors of the pituitary and gastrointestinal tract and non-neoplastic diseases of the gut.
    Gorden P; Comi RJ; Maton PN; Go VL
    Ann Intern Med; 1989 Jan; 110(1):35-50. PubMed ID: 2535688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Somatostatin in gastroenterological therapy].
    Stalder GA; Kayasseh L; Gyr K
    Schweiz Med Wochenschr Suppl; 1985; 19():30-6. PubMed ID: 2865809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical evaluation of SMS 201-995. Long-term treatment in gut neuroendocrine tumours, efficacy of oral administration, and possible use in non-tumoural inappropriate TSH hypersecretion.
    Williams G; Anderson JV; Williams SJ; Bloom SR
    Acta Endocrinol Suppl (Copenh); 1987; 286():26-36. PubMed ID: 2892335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indirect antiproliferative effect of the somatostatin analog octreotide on MIA PaCa-2 human pancreatic carcinoma in nude mice.
    Weckbecker G; Raulf F; Bodmer D; Bruns C
    Yale J Biol Med; 1997; 70(5-6):549-54. PubMed ID: 9825482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is octreotide a new hope for enterocutaneous and external pancreatic fistulas closure?
    Martineau P; Shwed JA; Denis R
    Am J Surg; 1996 Oct; 172(4):386-95. PubMed ID: 8873537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of acromegaly with octreotide, a synthetic analog of somatostatin with extended action].
    Arosio M; Bazzoni N; Faglia G
    Minerva Endocrinol; 1990; 15(1):29-36. PubMed ID: 2274011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Debut of a somatostatin analog: octreotide in review.
    Zindel LR
    Conn Med; 1989 Dec; 53(12):741-4. PubMed ID: 2558839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging indications for octreotide therapy, Part 2.
    Mosdell KW; Visconti JA
    Am J Hosp Pharm; 1994 May; 51(10):1317-30. PubMed ID: 8085570
    [No Abstract]   [Full Text] [Related]  

  • 18. [Closure of postoperative anastomotic fistulas with a somatostatin analogue].
    Niv Y; Hadari A; Asaf V; Oren M
    Harefuah; 1991 Jun; 120(11):647-8. PubMed ID: 1937211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role of somatostatin in the management of upper gastrointestinal bleeding].
    Herszényi L
    Orv Hetil; 2002 May; 143(19 Suppl):1092-9. PubMed ID: 12063868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Somatostatin analogues in treatment of gastrointestinal and pancreatic neuroendocrine tumors].
    Simonenko VB; Dulin PA; Makanin MA
    Klin Med (Mosk); 2006; 84(4):4-8. PubMed ID: 16755846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.